talinolol has been researched along with allopurinol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Boguschewski, KD; Brämer, U; Dobritz, H; Hitzeroth, T; Mann, D | 1 |
1 trial(s) available for talinolol and allopurinol
Article | Year |
---|---|
[Long-term studies on the beta blocker talinolol (cordanum) with special reference to side effects].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Allopurinol; Angina Pectoris; Arrhythmias, Cardiac; Double-Blind Method; Fatigue; Female; Headache; Humans; Hypertension; Male; Middle Aged; Phenylurea Compounds; Propanolamines; Sleep Initiation and Maintenance Disorders | 1979 |
3 other study(ies) available for talinolol and allopurinol
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |